Tao Li

This inventor holds 26 USPTO granted patents and 17 published patent applications, plus 7 CIPO patents and 8 EPO patents, primarily in Communication Systems. Top assignees: Qualcomm Incorporated, The University of North Carolina at Chapel Hill, General Electric Company. Active years: 2004-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tao Li. Retrieved from https://idiyas.com/inventor/tao-li-onrstye2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 17)

% Patents Active = 53.8

CIPO Patents = 7 (Patent Applications = 16)

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 216(Granted Patents)

Location History:

San Diego, CA (US) (2004 - 2017)
Blue Ash, OH (US) (2023)

Company Filing History:

15 out of 44,897

Qualcomm Incorporated

patents

10 out of 1,327

The University of North Carolina at Chapel Hill

patents

1 out of 52,387

General Electric Company

patents

Years Active: 2004-2023

Loading Chart...

Areas of Expertise:

Ceramic Matrix Composites

Vitamin K Proteins

Direct Conversion Receiver

Super-Heterodyne Transceiver

GPS Pilot Searcher

CDMA Communication

Variable Gain Amplification

Synchronous RAM Architecture

Error Correction Coding

Mobile Broadcast Receiver

Test Pattern Generation

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11827570 - Articles for creating hollow structures in ceramic matrix composites (2023-11-28),

2. 9828588 - Methods and compositions for producing active vitamin K-dependent proteins (2017-11-28),

3. 9441208 - Methods and compositions for producing vitamin K dependent proteins (2016-09-13),

4. 9374121 - Transceiver with super-heterodyne and zero intermediate frequency (ZIF) topologies (2016-06-21),

5. 8634790 - Direct conversion receiver architecture with digital fine resolution variable gain amplification (2014-01-21),

6. 8626099 - Direct conversion receiver architecture (2014-01-07),

7. 8615212 - Direct conversion receiver architecture (2013-12-24),

8. 8603823 - Methods and compositions for producing vitamin K dependent proteins (2013-12-10),

9. 8490124 - Method and apparatus for improving performance and user experience of a mobile broadcast receiver (2013-07-16),

10. 8426128 - Methods and compositions for vitamin K epoxide reductase (2013-04-23),

11. 8097410 - Methods and compositions for vitamin K epoxide reductase (2012-01-17),

12. 7858318 - Methods and compositions for vitamin K epoxide reductase (2010-12-28),

13. 7687233 - Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin K epoxide reductase gene and warfarin dosage (2010-03-30),

14. 7649860 - Buffer-based GPS and CDMA pilot searcher (2010-01-19),

15. 7645602 - Methods and compositions for producing vitamin K dependent proteins (2010-01-12),

Title: Innovations in Vitamin K-Dependent Proteins: The Contributions of Tao Li

Introduction

Tao Li, an accomplished inventor based in San Diego, California, has made significant strides in the field of biotechnology, particularly concerning vitamin K-dependent proteins. With an impressive portfolio of 25 patents, his innovative work continues to shape the landscape of protein production and therapeutic applications.

Latest Patents

Among Tao Li's latest patents are groundbreaking inventions aimed at enhancing the stability and production efficiency of vitamin K-dependent proteins. His first patent, titled "Methods and compositions for producing active vitamin K-dependent proteins," focuses on creating a stable cell line that overexpresses both recombinant vitamin K epoxide reductase (VKOR) and vitamin K-dependent gamma carboxylase (VKGC). This invention remarkably increases the yield of fully carboxylated VKD protein by 10%. Additionally, his patent on "Methods and compositions for producing vitamin K dependent proteins" relates to novel strategies for improving recombinant protein expression in host cells, highlighting his commitment to advancing biotechnological methods.

Career Highlights

Tao Li's professional journey includes prominent roles at leading institutions such as Qualcomm Incorporated and the University of North Carolina at Chapel Hill. His tenure at these esteemed organizations has provided him with a robust platform to collaborate and innovate within the domain of life sciences, significantly contributing to his extensive patent portfolio.

Collaborations

Throughout his career, Li has worked alongside distinguished colleagues, including Darrel W. Stafford and Inyup Kang. These collaborations have not only enriched his research perspective but have also fostered a synergistic approach to tackling complex problems in the biotechnological field.

Conclusion

In summary, Tao Li's contributions to the field of vitamin K-dependent proteins underscore his role as an influential inventor and researcher. His innovative approaches, highlighted by numerous patents, continue to impact the biotechnology landscape, paving the way for advancements in protein production and therapeutic solutions.

Profile summary based on public USPTO records.